157 related articles for article (PubMed ID: 15976726)
21. Efficacy of infliximab on the acute attack of uveitis.
Alokaily F; Alsaleh S; Al-Balawi M; Al-Rashidi S
Saudi Med J; 2010 Jan; 31(1):82-5. PubMed ID: 20062906
[TBL] [Abstract][Full Text] [Related]
22. [The prospects of the biotherapy for refractory uveitis].
Zheng YZ
Zhonghua Yan Ke Za Zhi; 2016 Jul; 52(7):551-6. PubMed ID: 27531117
[TBL] [Abstract][Full Text] [Related]
23. Local therapies for inflammatory eye disease in translation: past, present and future.
Tempest-Roe S; Joshi L; Dick AD; Taylor SR
BMC Ophthalmol; 2013 Aug; 13(1):39. PubMed ID: 23914773
[TBL] [Abstract][Full Text] [Related]
24. Intravitreal injection therapy in the treatment of noninfectious uveitis.
Modorati G; Miserocchi E
Dev Ophthalmol; 2012; 51():110-21. PubMed ID: 22517209
[TBL] [Abstract][Full Text] [Related]
25. Retrospective case review of pediatric patients with uveitis treated with infliximab.
Rajaraman RT; Kimura Y; Li S; Haines K; Chu DS
Ophthalmology; 2006 Feb; 113(2):308-14. PubMed ID: 16406545
[TBL] [Abstract][Full Text] [Related]
26. Infliximab for juvenile idiopathic arthritis-associated uveitis.
Richards JC; Tay-Kearney ML; Murray K; Manners P
Clin Exp Ophthalmol; 2005 Oct; 33(5):461-8. PubMed ID: 16181269
[TBL] [Abstract][Full Text] [Related]
27. Emerging drugs for the treatment of uveitis.
Leung TG; Thorne JE
Expert Opin Emerg Drugs; 2013 Dec; 18(4):513-21. PubMed ID: 24274613
[TBL] [Abstract][Full Text] [Related]
28. [Medium-long term treatment with infliximab and methotrexate in posterior and/or chronic uveitis refractory to conventional treatment].
Cobo-Ibáñez T; Muñoz-Fernández S; Hidalgo-Barrero V; Martín-Mola E
Med Clin (Barc); 2006 Jan; 126(1):34-5. PubMed ID: 16409950
[No Abstract] [Full Text] [Related]
29. New Immunosuppressive Therapies in Uveitis Treatment.
Mérida S; Palacios E; Navea A; Bosch-Morell F
Int J Mol Sci; 2015 Aug; 16(8):18778-95. PubMed ID: 26270662
[TBL] [Abstract][Full Text] [Related]
30. Anti-inflammatory therapy in uveitis.
Majumder PD; Sudharshan S; Biswas J
Recent Pat Inflamm Allergy Drug Discov; 2009 Nov; 3(3):188-94. PubMed ID: 19607645
[TBL] [Abstract][Full Text] [Related]
31. [Anti-TNF-α in the treatment of uveitis in the Besançon Hospital].
Fery-Blanco C; Schwartz C; Gil H; Curlier E; Prati C; Delbosc B
J Fr Ophtalmol; 2011 Dec; 34(10):697-702. PubMed ID: 21889230
[TBL] [Abstract][Full Text] [Related]
32. Immunosuppressive Treatment of Non-infectious Uveitis: History and Current Choices.
Zhao C; Zhang M
Chin Med Sci J; 2017 Apr; 32(1):48-61. PubMed ID: 28399985
[TBL] [Abstract][Full Text] [Related]
33. Treating intraocular inflammatory disease in the 21st century.
Nussenblatt R
Arch Ophthalmol; 2005 Jul; 123(7):1000-1. PubMed ID: 16009844
[No Abstract] [Full Text] [Related]
34. Golimumab in uveitis previously treated with other anti-TNF-alpha drugs: a retrospective study of three cases from a single centre and literature review.
Calvo-Río V; de la Hera D; Blanco R; Beltrán-Catalán E; Loricera J; Cañal J; Ventosa J; Cifrián JM; Ortiz-Sanjuán F; Rueda-Gotor J; González-Vela MC; González-López M; González-Gay MA
Clin Exp Rheumatol; 2014; 32(6):864-8. PubMed ID: 25288110
[TBL] [Abstract][Full Text] [Related]
35. Induction of regulatory T cells by infliximab in Behcet's disease.
Sugita S; Yamada Y; Kaneko S; Horie S; Mochizuki M
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):476-84. PubMed ID: 20861484
[TBL] [Abstract][Full Text] [Related]
36. [Clinical and epidemiological profile of pediatric uveitis, course of inflammatory uveitis treated with anti-TNF alpha].
Osswald D; Rameau AC; Speeg-Schatz C; Terzic J; Sauer A
J Fr Ophtalmol; 2018 May; 41(5):447-452. PubMed ID: 29778284
[TBL] [Abstract][Full Text] [Related]
37. The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: results of a multicentre open-label study.
Santos-Gómez M; Calvo-Río V; Blanco R; Beltrán E; Mesquida M; Adán A; Cordero-Coma M; García-Aparicio ÁM; Valls Pascual E; Martínez-Costa L; Hernández MV; Hernandez Garfella M; González-Vela MC; Pina T; Palmou-Fontana N; Loricera J; Hernández JL; González-Gay MA
Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S34-S40. PubMed ID: 27054359
[TBL] [Abstract][Full Text] [Related]
38. Infliximab in the treatment of refractory posterior uveitis.
Joseph A; Raj D; Dua HS; Powell PT; Lanyon PC; Powell RJ
Ophthalmology; 2003 Jul; 110(7):1449-53. PubMed ID: 12867408
[TBL] [Abstract][Full Text] [Related]
39. [Immunosuppressive therapy in intraocular inflammation. II. Basic principles, indications, contraindications, side-effects].
Manthey KF
Ophthalmologe; 1998 Dec; 95(12):846-58. PubMed ID: 10025150
[No Abstract] [Full Text] [Related]
40. Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 15 patients.
Calvo-Río V; Blanco R; Santos-Gómez M; Rubio-Romero E; Cordero-Coma M; Gallego-Flores A; Veroz R; Torre I; Hernández FF; Atanes A; Loricera J; González-Vela MC; Palmou N; Hernández JL; González-Gay MA
Semin Arthritis Rheum; 2016 Aug; 46(1):95-101. PubMed ID: 27060872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
